Skip to main content
. Author manuscript; available in PMC: 2021 Oct 9.
Published in final edited form as: Hepatology. 2020 Oct 9;72(4):1219–1229. doi: 10.1002/hep.31121

Table 3.

Performance diagnostics of 72-week relative change in PDFF in assessing histologic improvement and resolution of NASH

Event Prevalence of event Cross-validated AUROC (95% CI) Cutoff criteria Cutoff (Relative change in PDFF) Sens Spec PPV NPV
Histologic improvement 27% 0.60 (0.45, 0.75) Sens = 90% 23.1% Fixed 23% 30% 87%
Spec = 90% −57.3% 10% Fixed 29% 73%
Youden’s index −29.8% 48% 81% 48% 81%